Supernus Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from diseases of the central nervous system (CNS).
01-30-2009 Supernus Pharmaceuticals Initiates Phase IIa Clinical Trial for SPN810 in Conduct Disorder
Study Measures Safety and Tolerability of Novel Therapy for Treatment of Serious Conduct Problems in Children with ADHD read more...
